Influenza Testing - Impact of New Testing and New Testing Options

 

Influenza Testing — Impact of New Testing and New Testing Options

Glen T. Hansen, PhD, FCCM, D(ABMM), Ann Cox, MT (ASCP) and Kendra Schmidt, BS, MT(ASCP) discuss the epidemiology of influenza and the clinical challenges of assessing actual influenza patients. The trio of presenters also examine the contemporary challenges with applying molecular testing outside of the centralized laboratory, discuss the advantages and limitations of current testing options, review how rapid influenza test results can be applied to patient care, and describe the implementation and outcomes of applying rapid PCR to ancillary locations.

 

Previous Article
Leveraging Lab Data to Connect with the C-Suite
Leveraging Lab Data to Connect with the C-Suite

To get the attention of the organization's C-suite, labs must show how their data can contribute to data-dr...

Next Article
How to Solve Your C. Difficile Diagnosis Challenges
How to Solve Your C. Difficile Diagnosis Challenges

How a holistic approach to C. difficile management can help hospitals reduce their CDI rates.